Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
The International Journal of Neuroscience|February 21, 2020
High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastomaHang Yeon Jeong, Hyun-Jin Kim, Cheol-Eun Kim, et al.
IBRO Neuroscience Reports|August 1, 2022
Sprouty 1 is associated with stemness and cancer progression in glioblastomaSeo-Young Park, Hang Yeon Jeong, Don Carlo Batara, et al.
Journal of Animal Science and Technology|May 14, 2021
Inhibitory effects of Porphyra dentata extract on 3T3-L1 adipocyte differentiationSu-Young Choi, Su Yeon Lee, Da Hye Jang, et al.
The International Journal of Biochemistry & Cell Biology|June 29, 2013
Fanconi anemia complementation group A (FANCA) localizes to centrosomes and functions in the maintenance of centrosome integritySunshin Kim, Soo Kyung Hwang, Mihee Lee, et al.
CNS Neuroscience & Therapeutics|July 18, 2020
B3GNT5 is a novel marker correlated with stem-like phenotype and poor clinical outcome in human gliomasHang Yeon Jeong, Seo-Young Park, Hyun-Jin Kim, et al.
Molecules and Cells|September 4, 2010
The neural stem cell fate determinant TLX promotes tumorigenesis and genesis of cells resembling glioma stem cellsHyo-Jung Park, Jun-Kyum Kim, Hye-Min Jeon, et al.
Cancer Research|June 26, 2014
Crosstalk between glioma-initiating cells and endothelial cells drives tumor progressionHye-Min Jeon, Sung-Hak Kim, Xun Jin, et al.
Food Science and Biotechnology|May 9, 2022
Shinorine and porphyra-334 isolated from laver (Porphyra dentata) inhibit adipogenesis in 3T3-L1 cellsSu-Young Choi, Su Yeon Lee, Hyung Gyun Kim, et al.
Food Science of Animal Resources|April 30, 2026
Interconnection of the Gut-Skin Axis in NC/Nga Mouse with Atopic Dermatitis: Effects of the Three Types of Bifidobacterium bifidum CBT-BF3 (Probiotics, Postbiotics, and Cytosine-Phosphate-Guanine Oligodeoxynucleotide) on T Cell Differentiation and Gut MicrobiotaGwang Il Kim, Hwa Yeong Jeong, In Sung Kim, et al.
Molecular Cancer Therapeutics|March 19, 2008
Combined lapatinib and cetuximab enhance cytotoxicity against gefitinib-resistant lung cancer cellsHwang-Phill Kim, Sae-Won Han, Sung-Hak Kim, et al.
Pageof 11